×
Customize
?
Start
Cancer Types
Quick Links
Advocacy & Research
Events
Award Programs
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
Latest Partner Content
Neena Kennedy, from the Leukemia and Lymphoma Society, offers advice on how to find out about and join clinical trials.
Having someone to talk to through the cancer journey is vital, especially when that person is a fellow survivor that can understand the challenges of treatment.
Mona P is finding hope, life and healing after carcinoma of the pharynx.
Hope can be a major part of a patient's cancer journey.
The Bladder Cancer Advocacy Network announces it's Bladder Cancer Research Innovation Award.
FDA has given an accelerated approval to Padcev in the treatment of patients with locally advanced or metastatic urothelial cancer.
The Bladder Cancer Advocacy Network (BCAN) is pleased to announce two 2020 Young Investigator Awards (YIA), to support the development of outstanding early-career research scientists and clinical cancer research investigators.
At 15 years old the Bladder Cancer Advocacy Network looks back and takes a look ahead.
Men with metastatic castration-sensitive prostate cancer will now have a fourth treatment option to consider.
In this week’s episode of the “CURE Talks Cancer” podcast, we spoke with Lisa Schlager, from FORCE, about the types of legal protections in place for those with a genetic risk for cancer.